| Literature DB >> 26775918 |
Giuseppe Cabibbo1, Maria Reig2,3, Gennaro Gadaleta-Caldarola4, Giovanni Galati5, Giuseppe Lombardi6, GianCarlo Mazza7, Luca Marzi8, Carlo Saitta9, Jean-Charles Nault10,11,12, Rodolfo Sacco13.
Abstract
International Liver Cancer Association Congress 2015, Paris, France, 4-6 September 2015 Since its creation 9 years ago, in 2007, the International Liver Cancer Association has focused on the multidisciplinary approach to liver cancer due to advances in hepatology science and care worldwide. In its 2015 annual conference, held on 4-6 September in Paris, France, the most recent progresses in the basic biology, management and treatment of liver cancer have been presented. This report, divided into two parts, introduces and critically reviews some of the most intriguing topics discussed at the meeting.Entities:
Keywords: HCC; immunotherapy; liver cancer; prognosis; sorafenib; staging system; survival; trial design
Mesh:
Year: 2016 PMID: 26775918 DOI: 10.2217/fon.15.323
Source DB: PubMed Journal: Future Oncol ISSN: 1479-6694 Impact factor: 3.404